Citation: | GONG Yi-xiao, SONG Xiao-hong, XU Juan, DU Jia-yue, XIE Li-chun, . Neonatal genetic metabolic disease entities ought to be included in tandem mass spectrometry screening in China[J]. Chinese Journal of Public Health, 2022, 38(1): 20-24. doi: 10.11847/zgggws1134514 |
[1] |
史雅萍, 王宇君, 李红霞, 等. 新生儿遗传代谢病筛查研究进展[J]. 中国优生与遗传杂志, 2017, 25(3): 119 – 120.
|
[2] |
赵正言. 新生儿疾病筛查在我国的发展[J]. 中国儿童保健杂志, 2011, 19(2): 97 – 98, 101.
|
[3] |
崔岚. 串联质谱在新生儿疾病筛查中的应用进展[J]. 中国优生与遗传杂志, 2015, 23(9): 8 – 10.
|
[4] |
赵正言. 国际新生儿疾病筛查进展[J]. 中国儿童保健杂志, 2012, 20(3): 193 – 195.
|
[5] |
赵正言, 顾学范. 新生儿遗传代谢病筛查[M]. 2版. 北京: 人民卫生出版社, 2015.
|
[6] |
黄世荣, 翁景文. 新生儿疾病筛查及其治疗的研究进展[J]. 中国临床研究, 2013, 26(6): 604 – 606.
|
[7] |
卫生部临床检验中心新生儿遗传代谢疾病筛查室质量评价委员会. 新生儿疾病串联质谱筛查技术专家共识[J]. 中华检验医学杂志, 2019, 42(2): 89 – 97. doi: 10.3760/cma.j.issn.1009-9158.2019.02.004
|
[8] |
国家药品监督管理局医疗器械技术审评中心. 氨基酸、肉碱及琥珀酰丙酮检测试剂注册技术审查指导原则(2019年第80号)[EB/OL]. (2019 – 11 – 15)[2019 – 12 – 30]. https://www.cmde.org.cn/CL0112/20006.html.
|
[9] |
Department of Health and Human Services, USA. Recommended uniform screening panel[EB/OL]. [2019 – 08 – 28]. https://www.hrsa.gov/advisory-committees/heritable-disorders/rusp/index.html.
|
[10] |
Canadian Organization for Rare Disorders. Newborn screening in Canada status report[EB/OL]. (2015 – 09 – 03)[2019 – 08 – 28]. http://www.raredisorders.ca/content/uploads/Canada-NBS-status-updated-Sept.-3-2015.pdf.
|
[11] |
Public Health England. Newborn blood spot screening: programme overview[EB/OL]. [2019 – 08 – 28]. https://www.gov.uk/guidance/newborn-blood-spot-screeningprogramme-overview.
|
[12] |
Gemeinsamer Bundesausschuss. des gemeinsamen bundesauss-chusses über die früherkennung von krankheiten bei kindern (Kinder-Richtlinie)[EB/OL]. [2019 – 08 – 28]. https://www.g-ba.de/downloads/62-492-1998/Kinder-RL_2019-1-14_iK-2019-12-19.pdf.
|
[13] |
Health Genetics Society of Australasia. Recommendations for screening for specific disorders 2017[EB/OL]. [2019 – 08 – 29]. https://www.hgsa.org.au/resources/hgsapolicies-and-position-statements.
|
[14] |
National Screening Unit, NewZealand. Newborn Metabolic Screen-ing Programme-heel prick test[EB/OL]. (2014 – 12 – 01)[2019 – 08 – 29]. https://www.nsu.govt.nz/pregnancy-newborn-screening/newborn-metabolic-screening-programme-heel-prick-test.
|
[15] |
Shibata N, Hasegawa Y, Yamada K, et al. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: selective screening vs. expanded newborn screening[J]. Molecular Genetics and Metabolism Reports, 2018, 16: 5 – 10. doi: 10.1016/j.ymgmr.2018.05.003
|
[16] |
Niu DM, Chien YH, Chiang CC, et al. Nationwide survey of extended newborn screening by tandem mass spectrometry in Taiwan[J]. Journal of Inherited Metabolic Disease, 2010, 33(S2): 295 – 305. doi: 10.1007/s10545-010-9129-z
|
[17] |
上海市儿童医院筛查中心. 串联质谱筛查: 新生儿疾病的病种[EB/OL]. [2019 – 08 – 29]. http://www.61mk.cn/news_show.php?id=161.
|
[18] |
黄新文, 张玉, 洪芳, 等. 浙江省新生儿氨基酸代谢疾病筛查及随访分析[J]. 浙江大学学报: 医学版, 2017, 46(3): 233 – 239.
|
[19] |
洪芳, 黄新文, 张玉, 等. 浙江省新生儿有机酸尿症筛查及随访分析[J]. 浙江大学学报: 医学版, 2017, 46(3): 240 – 247.
|
[20] |
郑静, 张玉, 洪芳, 等. 浙江省新生儿脂肪酸氧化代谢疾病筛查及随访分析[J]. 浙江大学学报: 医学版, 2017, 46(3): 248 – 255.
|
[21] |
Wilson JMG, Jungner G. The principles and practice of screening for disease[R]. Geneva: World Health Organization, 1968.
|
[22] |
田国力, 王燕敏, 许洪平, 等. 非衍生化串联质谱技术筛查上海部分地区新生儿遗传代谢病的回顾性分析[J]. 临床检验杂志, 2016, 34(12): 909 – 912.
|
[23] |
黄新文, 杨建滨, 童凡, 等. 串联质谱技术对新生儿遗传代谢病的筛查及随访研究[J]. 中华儿科杂志, 2011, 49(10): 765 – 770. doi: 10.3760/cma.j.issn.0578-1310.2011.10.013
|
[24] |
鄢慧明, 贾政军, 刘静, 等. 湖南省565182例串联质谱新生儿疾病筛查分析[J]. 中华实用儿科临床杂志, 2019, 34(20): 1541 – 1545. doi: 10.3760/cma.j.issn.2095-428X.2019.20.006
|